Abstract
Burkitt-lymphoma is a rare disease, that belongs to the aggressive Non-Hodgkin-lymphomas. Next to histology, that shows a characteristic pattern, and immunophenotyping additional cytogenetic and molecular biology techniques are used to demonstrate in most cases a translocation of the oncogen c-myc on chromosome 8 to any of the immunoglobulin genes on chromosome 14, 2 or 22. With short term intensive chemotherapies a cure rate of 85-95% of patients with Burkitt-lymphoma can be obtained today.
Publication types
-
Case Reports
-
English Abstract
MeSH terms
-
Adult
-
Antineoplastic Combined Chemotherapy Protocols
-
Bleomycin / therapeutic use
-
Burkitt Lymphoma / diagnosis*
-
Burkitt Lymphoma / drug therapy*
-
Cyclophosphamide / therapeutic use
-
Cytarabine / therapeutic use
-
Diagnosis, Differential
-
Epirubicin / therapeutic use
-
Etoposide / therapeutic use
-
Female
-
Humans
-
Methotrexate / therapeutic use
-
Prednisone / therapeutic use
-
Vincristine / therapeutic use
Substances
-
Cytarabine
-
Bleomycin
-
Epirubicin
-
Vincristine
-
Etoposide
-
Cyclophosphamide
-
Prednisone
-
Methotrexate